Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids

Peritoneal Dialysis International

Volumn 19, Issue 4, 1999, Pages 325-333

  Schalkwijk, Casper G ^a   Posthuma, Nynke ^a   Ten Brink, Herman J ^b   Ter Wee, Pieter M ^a   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Free University Hospital ^*

Author keywords

3 Deoxyglucosone; Advanced glycation end products; AGEs; Glyoxal; Methylglyoxal; Peritoneal dialysis fluids

Indexed keywords

1,2 DICARBONYL DERIVATIVE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; AMINOGUANIDINE; GLUCOSE; GLYOXAL; METHYLGLYOXAL; PERITONEAL DIALYSIS FLUID; QUINOXALINE DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FILTER; FLUORESCENCE ANALYSIS; GLYCATION; HIGH TEMPERATURE PROCEDURES; HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TIME;

EID: 0033432844     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089901900408     Document Type: Article

References (40)

1. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40:77-9.
2. Bronswijk H, Verbrugh HA, Bos HJ, Heezius EC, Oe PL, Van der Meulen J, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
3. Wieslander AP, Kjellstrand PT, Rippe B. Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations. Perit Dial Int 1995; 15(Suppl 1):S52-60.
4. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PT, Boberg UC. Heat sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39:343-8.
5. Jonasson P, Bagge U, Wieslander A, Braide M. Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules. Perit Dial Int 1996; 16(Suppl 1):S137-40.
6. Nilsson-Thorell CB, Muscalu N, Andren AHG, Kjellstrand PTT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
7. Wieslander A, Forsback G, Svensson E, Linden T. Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1996; 12:57-60.
8. Kjellstrand P, Martinson E, Wieslander A, Holmquist B. Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature. Perit Dial Int 1995; 15:26-32.
9. Legge M, Lash GE, Bird SD, Walker RJ. Formaldehyde in heat sterilized peritoneal dialysis solutions: scavenging system for its removal. Perit Dial Int 1998; 18:228-31.
10. Wieslander AP. Cytotoxicity of peritoneal dialysis fluid - is it related to glucose breakdown products? Nephrol Dial Transplant 1996; 11:958-9.
11. Wieslander A, Linden T. Glucose degradation and cytotoxicity in PD fluids. Perit Dial Int 1996; 16(Suppl 1):S114-18.
12. Wieslander AP, Andren AH, Nilsson-Thorell C, Muscalu N, Kjellstrand PT, Rippe B. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995; 15:348-52.
13. Topley N, Alobaidi HMM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34:404-11.
14. Linden T, Forsbäck G, Deppisch R, Henle T, Wieslander A. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998; 18:290-3.
15. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissues and the biochemical basis of diabetic complications. N Engl J Med 1988; 318:1315-21.
16. Edelstein D, Brownlee M. Mechanistic studies of advanced glycation end product inhibition by amino-guanidine. Diabetes 1992; 41:26-9.
17. Lo TW, Selwood T, Thornalley PJ. The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol 1994; 48:1865-70.
18. Lamb EJ, Cattell WR, Dawnay AB. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. Kidney Int 1995; 47:1768-74.
19. Dawnay AB, Millar DJ. Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int 1997; 17:52-8.
20. Dawnay AB. Advanced glycation end products in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1):S50-3.
21. Lamb E, Cattell WR, Dawnay AB. Glycated albumin in serum and dialysate of patients on continuous ambulatory peritoneal dialysis. Clin Sci 1993; 84:619-26.
22. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, et al. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal diseases. Clin Nephrol 1994; 42:354-61.
23. Mahiout A, Ehlerding G, Brunkhorst R. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. Nephrol Dial Transplant 1996; 11(Suppl 5):2-6.
24. McLellan AC, Thornalley PJ. Synthesis and chromatography of 1,2-diamino-4,5-dimethoxybenzene, 6,7-dimethoxy-2-methylquinoxalirie and 6,7-dimethoxy-2,3-dimethylquinoxaline for use in a liquid chromatographic fluorimetric assay of methylglyoxal. Anal Chim Acta 1992; 263:137-42.
25. McLellan AC, Phillips SA, Thornalley PJ. The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 1992; 206:17-23.
26. Khadem HE, Horton D, Meshreki MH, Nashed MA. New route for the synthesis of 3-deoxyaldos-2-uloses. Carbohydr Res 1971; 17:183-92.
27. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 1987; 245:243-50.
28. Wells-Knecht JKJ, Zyzak DV, Litchfield JE, Thorpe S, Baynes JW. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995; 34:3702-9.
29. Niwa T, Katsuzaki T, Momoi T, Miyazaki T, Ogawa H, Saito A, et al. Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 1996; 49:861-7.
30. Kato H, van Chuyen N, Shinoda T, Sekiya F, Hayase F. Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats. Biochem Biophys Acta 1990; 1035:71-6.
31. Sato K, Inazu A, Yamaguchi S, Nakayama T, Deyashiki Y, Sawada H, et al. Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase and aldose reductase. Arch Biochem Biophys 1993; 307: 286-94.
32. Okado A, Kawasaki Y, Hasuike Y, Takahashi M, Teshima T, Fujii J, et al. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 1996; 225:219-24.
33. Kang Y. Edwards LG, Thornalley PJ. Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA, G1, growth arrest and induction of apoptosis. Leuk Res 1996; 20:397-405.
34. Che W, Asahi M, Takahashi M, Kaneto H, Okado A, Higashiyama S, et al. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes. J Biol Chem 1997; 272: 18453-9.
35. Westwood ME, Thornalley PJ. Induction of synthesis and secretion of interleukin 1 beta in the human monocytic THP-1 cells by human serum albumins modified with methylglyoxal and advanced glycation end-products. Immunol Lett 1996; 50:17-21.
36. Abordo EA, Thornalley PJ. Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol Lett 1997; 58:139-47.
37. Abordo EA, Westwood ME, Thornalley PJ. Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol Lett 1996; 53:7-13.
38. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulation properties. J Exp Med 1989; 170:1387-407.
39. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996; 1:238-43.
40. Wieslander AP, Deppisch R, Svensson E, Forsback G, Speidel R, Rippe B. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Peril Dial Int 1995; 15:158-64.